Answers are grounded in this paper and cite their sources.
Analysis shows functional diffusion mapping and ADC metrics can predict relapse-free survival in head and neck cancer, implying enhanced treatment personalization.
Motivation: Head and neck cancer outcomes vary widely with radiation therapy (RT). Changes in ADC from DWI during RT might predict response, but the optimal time points and metrics are unclear. Goal(s): We tested full-tumor ADC and voxel-wise Functional Diffusion Mapping (fDM) metrics as predictors of relapse-free survival (RFS) at 6- and 24-months post-RT. Approach: ADC and fDM metrics were analyzed at multiple RT time points for 60 patients. Logistic regression modeling was used to identify the strongest predictors of RFS. Results: ADC metrics predicted 6-month RFS more effectively than 24-month, with fDM metrics showing potential as indicators of early RT response. Impact: This study is the first to apply Functional Diffusion Mapping (fDM) in head and neck cancer, revealing its potential to improve adaptive radiation therapy by identifying early predictors of response, which may guide personalized treatment adjustments for better outcomes.
No takes yet. Share an insight, caveat, or question.
McDonald et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: